Twist Bioscience Corporation (TWST)
Largest Insider Buys in Sector
TWST Stock Price History Chart
TWST Stock Performance
About Twist Bioscience Corporation
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical …
Insider Activity of Twist Bioscience Corporation
Over the last 12 months, insiders at Twist Bioscience Corporation have bought $0 and sold $3.53M worth of Twist Bioscience Corporation stock.
On average, over the past 5 years, insiders at Twist Bioscience Corporation have bought $191,048 and sold $61.77M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $132,000 was made by Cho Dennis (See Remarks) on 2023‑05‑10.
List of Insider Buy and Sell Transactions, Twist Bioscience Corporation
| 2024-10-23 | Sale | President and COO | 2,261 0.0038% | $43.09 | $97,429 | 0.00% | ||
| 2024-10-09 | Sale | Chief Financial Officer | 856 0.0013% | $41.81 | $35,791 | +7.29% | ||
| 2024-10-02 | Sale | Chief Executive Officer | 13,605 0.0213% | $43.21 | $587,886 | -0.68% | ||
| 2024-10-02 | Sale | President and COO | 6,865 0.0108% | $43.21 | $296,644 | -0.68% | ||
| 2024-10-02 | Sale | SVP of Human Resources | 3,310 0.0052% | $43.21 | $143,028 | -0.68% | ||
| 2024-10-02 | Sale | See Remarks | 3,104 0.0049% | $43.21 | $134,127 | -0.68% | ||
| 2024-09-20 | Sale | Chief Executive Officer | 1,730 0.003% | $46.94 | $81,208 | -6.68% | ||
| 2024-09-20 | Sale | SVP of Human Resources | 297 0.0005% | $46.94 | $13,941 | -6.68% | ||
| 2024-09-20 | Sale | See Remarks | 234 0.0004% | $46.94 | $10,984 | -6.68% | ||
| 2024-09-16 | Sale | See Remarks | 94 0.0002% | $46.42 | $4,364 | -4.49% | ||
| 2024-09-06 | Sale | Chief Executive Officer | 2,340 0.0043% | $39.16 | $91,637 | +21.24% | ||
| 2024-09-06 | Sale | SVP of Human Resources | 912 0.0017% | $39.16 | $35,715 | +21.24% | ||
| 2024-09-06 | Sale | See Remarks | 275 0.0005% | $39.16 | $10,769 | +21.24% | ||
| 2024-09-06 | Sale | Chief Accounting Officer | 240 0.0004% | $39.16 | $9,399 | +21.24% | ||
| 2024-08-23 | Sale | Chief Accounting Officer | 813 0.0014% | $43.14 | $35,074 | +0.73% | ||
| 2024-08-05 | Sale | Chief Executive Officer | 5,139 0.0078% | $39.93 | $205,180 | -2.98% | ||
| 2024-08-05 | Sale | President and COO | 2,885 0.0044% | $39.93 | $115,187 | -2.98% | ||
| 2024-08-05 | Sale | SVP of Human Resources | 1,137 0.0017% | $39.93 | $45,396 | -2.98% | ||
| 2024-08-05 | Sale | See Remarks | 709 0.0011% | $39.93 | $28,308 | -2.98% | ||
| 2024-08-05 | Sale | Chief Accounting Officer | 168 0.0003% | $39.93 | $6,708 | -2.98% |
Insider Historical Profitability
| Cho Dennis | See Remarks | 75289 0.1285% | $44.95 | 1 | 14 | +82.06% |
| ARCH Venture Partners VIII, LLC | 10 percent owner | 2407422 4.1092% | $44.95 | 1 | 0 | +78.29% |
| BARTHELEMY NICOLAS | 13939 0.0238% | $44.95 | 1 | 1 | +9.24% | |
| CRANDELL KEITH | director | 486 0.0008% | $44.95 | 1 | 2 | +78.29% |
Institutional Investor Ownership
| ARK Investment Management LLC | $238.25M | 11.93 | 6.94M | -3.73% | -$9.24M | 0.82 | |
| BlackRock | $198.14M | 9.92 | 5.77M | -2.9% | -$5.92M | <0.01 | |
| The Vanguard Group | $187.41M | 9.38 | 5.46M | -0.24% | -$449,117.90 | <0.01 | |
| Artisan Partners | $159.25M | 7.97 | 4.64M | +24.66% | +$31.51M | 0.24 | |
| JPMorgan Chase | $123.99M | 6.21 | 3.61M | -21.71% | -$34.38M | 0.01 |